Tower Research Capital LLC (Trc) Oncolytics Biotech Inc Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,017 shares of ONCY stock, worth $1,916. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,017
Previous 3,239 37.73%
Holding current value
$1,916
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.87 - $1.08 $1,063 - $1,319
-1,222 Reduced 37.73%
2,017 $1,000
Q2 2024

Aug 13, 2024
BUY
$0.99 - $1.24 $3,206 - $4,016
3,239 New
3,239 $3,000
Q4 2023

Feb 13, 2024
BUY
$1.22 - $2.09 $20 - $35
17 New
17 $0
Q2 2023

Aug 14, 2023
SELL
$1.11 - $2.74 $14,849 - $36,655
-13,378 Reduced 83.52%
2,639 $6,000
Q1 2023

May 09, 2023
BUY
$1.2 - $1.91 $12,482 - $19,867
10,402 Added 185.25%
16,017 $19,000
Q4 2022

Feb 10, 2023
BUY
$1.17 - $2.12 $2,108 - $3,820
1,802 Added 47.26%
5,615 $9,000
Q3 2022

Nov 10, 2022
SELL
$0.98 - $1.51 $2,360 - $3,637
-2,409 Reduced 38.72%
3,813 $5,000
Q2 2022

Aug 15, 2022
BUY
$0.85 - $1.59 $4,483 - $8,387
5,275 Added 557.02%
6,222 $6,000
Q1 2022

May 12, 2022
SELL
$1.31 - $2.02 $1,004 - $1,549
-767 Reduced 44.75%
947 $2,000
Q4 2021

Feb 14, 2022
BUY
$1.39 - $2.3 $2,382 - $3,942
1,714 New
1,714 $3,000
Q3 2021

Nov 15, 2021
SELL
$1.93 - $2.77 $4,168 - $5,983
-2,160 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$2.6 - $4.64 $5,616 - $10,022
2,160 New
2,160 $6,000
Q4 2020

Feb 16, 2021
SELL
$1.71 - $4.03 $102 - $241
-60 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$1.58 - $2.15 $94 - $129
60 New
60 $0

Others Institutions Holding ONCY

# of Institutions
44
Shares Held
1.18M
Call Options Held
0
Put Options Held
0
View Full List

About ONCOLYTICS BIOTECH INC

ONCY Quotes by TradingView
  • Ticker ONCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,867,400
  • Market Cap $55M
  • Description
  • Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...
More about ONCY
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email